Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04940611

A Study of Surgical Interventions in Fistulizing Conditions

SPOTLITE: Prospective Observational Study on the Clinical Outcomes of Surgical Interventions in Complex Fistulizing Conditions (CPF-CD, CD-RVF, CCF)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
750 (estimated)
Sponsor
Takeda · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study, participants with complex fistulizing conditions will be treated with surgical interventions according to their clinic's standard practice. The aim of the study is to generate real-world evidence on standard of care for surgical interventions and related outcomes when treating complex fistulizing conditions. The study sponsor will not be involved in how participants are treated but will provide instructions on how the clinics will record what happens during the study.

Detailed description

This is a non-interventional, prospective study of participants with complex fistulizing conditions (CPF-CD, CD develops CD-RVF and CCF) who are currently undergoing surgical intervention in the real world clinical setting. The study will enroll approximately 750 participants. The data will be collected prospectively at the study sites and will be recorded into electronic data capture forms (EDCs). Participants will be enrolled to the following observational cohorts: * Participants With CPF-CD * Participants With CD-RVF * Participants With CCF This multi-center study will be conducted in the United States, Canada, Europe, and Israel. Participants undergoing surgical interventions to treat fistulas will be enrolled from surgical and gastrointestinal (GI) specialty sites. The overall duration of the study will be 24 months. Data will be collected at baseline with follow-up information collected approximately every 3 to 6 months.

Conditions

Timeline

Start date
2021-08-05
Primary completion
2026-05-02
Completion
2026-05-02
First posted
2021-06-25
Last updated
2026-02-18

Locations

41 sites across 10 countries: United States, Austria, Belgium, Canada, Czechia, France, Israel, Italy, Netherlands, United Kingdom

Source: ClinicalTrials.gov record NCT04940611. Inclusion in this directory is not an endorsement.